Adial Pharmaceuticals releases a peer-reviewed article on AD04, its lead investigational drug for Alcohol Use Disorder. The study highlights a strong safety profile & liver safety compared to a placebo. Read this story
Adial Pharmaceuticals releases a peer-reviewed article on AD04, its lead investigational drug for Alcohol Use Disorder. The study highlights a strong safety profile & liver safety compared to a placebo. Read this story
More from Benzinga | PageIsBzPro: BZ CMS: WordPress category: Biotech category: News category: Health Care category: Exclusives category: General symbol: ADIL tag: Briefs tag: Stories That Matter Adial Pharmaceuticals Alcoholism Pharmaceutical industry Safety